Navigation Links
An Israel prize in his genes
Date:3/7/2011

Prof. Yosef Shiloh of Tel Aviv University's Sackler Faculty of Medicine will receive the 2011 Israel Prize, Israel's most distinguished national honor, at a state ceremony in Jerusalem this May. The prize is awarded by the Israeli Ministry of Education.

Prof. Shiloh's award brings the university's total to 70 Israel Prizes since the 1953 inception of the award.

Prof. Shiloh will receive the prize in the presence of Israeli President Shimon Peres, Israeli Prime Minister Benjamin Netanyahu and a host of other dignitaries. Award recipients, who must be Israeli citizens, can be individuals or groups that have demonstrated excellence or broken ground in a certain field. The Israel Award is given each year on the eve of the Israeli Day of Independence.

Earlier this year Prof. Shiloh was the first Israeli to receive the distinguished Clowes Award from the American Association for Cancer Research, the world's largest organization for such research.

A career on the cutting edge of science

Prof. Shiloh, a genetics professor, is being recognized for his breakthrough research in locating the specific gene that can protect inherited cellular material. His research provided the basis for a new understanding of the way this material impacts cancer and cell biology, leading other researchers to identify genetic defects in human beings.

Prof. Yosef Shiloh was born in 1949. After studying at the Technion and Hebrew University, he did postgraduate work at the University of Chicago and Harvard University.

He became a Tel Aviv University faculty member at the Sackler Faculty of Medicine's human genetics department in 1985, continuing his work on human genome research with Prof. Francis Collins at the University of Michigan. At Collins' lab, Prof. Shiloh discovered how to identify the gene mutation for the incurable genetic disease ataxia telangiectasia. At Tel Aviv University he further developed this work on the defective protein that causes the disease.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related biology news :

1. Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv
2. Life expectancy higher in Israel than in US, according to Ben-Gurion U. researcher
3. Renewable energy research center to be established in southern Israel
4. Innovotech signs agreement for distribution of its bioFILM PA test in Israel
5. A baby, Skype and water research partnership with Israel
6. NTU ramps up collaboration with Israels top university
7. Cellcom Israel Ltd. Announces Dismissal of a Purported Class Action
8. Single gene dramatically boosts yield, sweetness in tomato hybrids, CSHL-Israeli study finds
9. Why Israeli rodents are more cautious than Jordanian ones
10. Now butterflies are also being counted in China, Australia and Israel
11. Winners to share $1 million prize in Office of Naval Research challenge
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
An Israel prize in his genes
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology: